A carregar...
Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration
Fusidic acid (FA), which was approved in the 1960s in many European and Asian countries, has gained renewed interest due to its continued effectiveness against methicillin-resistant Staphylococcus aureus. As rhabdomyolysis has been reported upon coadministration of FA with statins, we aimed to eluci...
Na minha lista:
Publicado no: | Antimicrob Agents Chemother |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society for Microbiology
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038258/ https://ncbi.nlm.nih.gov/pubmed/27458210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01335-16 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|